Cargando…

Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report

Capicua transcriptional repressor (CIC)-rearranged sarcoma is an Ewing-like sarcoma with an aggressive clinical course and poor prognosis. No standard treatment has been established. The present study describes a case of CIC-rearranged sarcoma with lung metastases developing in a 24-year-old woman a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimbara, Shiro, Imamura, Yoshinori, Kiyota, Naomi, Takakura, Hidetomo, Matsumoto, Sakuya, Koyama, Taiji, Fujishima, Yoshimi, Funakoshi, Yohei, Toyoda, Masanori, Hirose, Takanori, Kanzawa, Maki, Kawamoto, Teruya, Hara, Hitomi, Minami, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890439/
https://www.ncbi.nlm.nih.gov/pubmed/33680459
http://dx.doi.org/10.3892/mco.2021.2230
_version_ 1783652514945564672
author Kimbara, Shiro
Imamura, Yoshinori
Kiyota, Naomi
Takakura, Hidetomo
Matsumoto, Sakuya
Koyama, Taiji
Fujishima, Yoshimi
Funakoshi, Yohei
Toyoda, Masanori
Hirose, Takanori
Kanzawa, Maki
Kawamoto, Teruya
Hara, Hitomi
Minami, Hironobu
author_facet Kimbara, Shiro
Imamura, Yoshinori
Kiyota, Naomi
Takakura, Hidetomo
Matsumoto, Sakuya
Koyama, Taiji
Fujishima, Yoshimi
Funakoshi, Yohei
Toyoda, Masanori
Hirose, Takanori
Kanzawa, Maki
Kawamoto, Teruya
Hara, Hitomi
Minami, Hironobu
author_sort Kimbara, Shiro
collection PubMed
description Capicua transcriptional repressor (CIC)-rearranged sarcoma is an Ewing-like sarcoma with an aggressive clinical course and poor prognosis. No standard treatment has been established. The present study describes a case of CIC-rearranged sarcoma with lung metastases developing in a 24-year-old woman as a therapy-associated malignancy following chemotherapy for anaplastic large cell lymphoma at nine years old. This was treated with palliative regimens used for Ewing sarcoma. The patient achieved disease control for one year. Of note, ifosfamide and etoposide (IE), which were used as a second line treatment lead to a partial response. The case described in the present study indicated that treatment with Ewing regimens is a reasonable option for patients with metastatic CIC-rearranged sarcoma, including those with a second malignant case.
format Online
Article
Text
id pubmed-7890439
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-78904392021-03-05 Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report Kimbara, Shiro Imamura, Yoshinori Kiyota, Naomi Takakura, Hidetomo Matsumoto, Sakuya Koyama, Taiji Fujishima, Yoshimi Funakoshi, Yohei Toyoda, Masanori Hirose, Takanori Kanzawa, Maki Kawamoto, Teruya Hara, Hitomi Minami, Hironobu Mol Clin Oncol Articles Capicua transcriptional repressor (CIC)-rearranged sarcoma is an Ewing-like sarcoma with an aggressive clinical course and poor prognosis. No standard treatment has been established. The present study describes a case of CIC-rearranged sarcoma with lung metastases developing in a 24-year-old woman as a therapy-associated malignancy following chemotherapy for anaplastic large cell lymphoma at nine years old. This was treated with palliative regimens used for Ewing sarcoma. The patient achieved disease control for one year. Of note, ifosfamide and etoposide (IE), which were used as a second line treatment lead to a partial response. The case described in the present study indicated that treatment with Ewing regimens is a reasonable option for patients with metastatic CIC-rearranged sarcoma, including those with a second malignant case. D.A. Spandidos 2021-04 2021-02-08 /pmc/articles/PMC7890439/ /pubmed/33680459 http://dx.doi.org/10.3892/mco.2021.2230 Text en Copyright: © Kimbara et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Kimbara, Shiro
Imamura, Yoshinori
Kiyota, Naomi
Takakura, Hidetomo
Matsumoto, Sakuya
Koyama, Taiji
Fujishima, Yoshimi
Funakoshi, Yohei
Toyoda, Masanori
Hirose, Takanori
Kanzawa, Maki
Kawamoto, Teruya
Hara, Hitomi
Minami, Hironobu
Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report
title Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report
title_full Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report
title_fullStr Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report
title_full_unstemmed Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report
title_short Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report
title_sort secondary cic-rearranged sarcoma responsive to chemotherapy regimens for ewing sarcoma: a case report
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890439/
https://www.ncbi.nlm.nih.gov/pubmed/33680459
http://dx.doi.org/10.3892/mco.2021.2230
work_keys_str_mv AT kimbarashiro secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT imamurayoshinori secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT kiyotanaomi secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT takakurahidetomo secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT matsumotosakuya secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT koyamataiji secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT fujishimayoshimi secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT funakoshiyohei secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT toyodamasanori secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT hirosetakanori secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT kanzawamaki secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT kawamototeruya secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT harahitomi secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport
AT minamihironobu secondarycicrearrangedsarcomaresponsivetochemotherapyregimensforewingsarcomaacasereport